http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1420570-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30432c021c19453629a3b69ce104640e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-89 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
| filingDate | 1974-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1976-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1420570-A |
| titleOfInvention | Pyridine n-oxides |
| abstract | 1420570 Pyridine N-oxides PARKE DAVIS & CO 19 Feb 1974 [20 Feb 1973] 7616/74 Heading C2C Novel compounds (I) where Het signifies 4- or 6-methyl- or 3- or 5- chloro-2-pyridyl 1-oxide, or 5-bromo-2-pyridyl 1-oxide or 3,5-dichloro-2-pyridyl 1-oxide, are made by reacting Het. SH or its alkali metal salt with 2-bromo-5-nitro-thiazole. The following compounds are also prepared: 2,5 and 2,3-dichloropyridine oxides, 2-bromo-3,5- dichloropyridine oxide, 3- and 5-chloro-2-mercapto-pyridine oxides and 3,5-dichloro-2-mercapto-pyridine oxide. Pharmaceutical preparations having antifungal and antibacterial actions contain (I) as active ingredient. Administration is orally, parenterally or topically. |
| priorityDate | 1973-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.